MDR cost and timing depend on device families, classification, available clinical data, verification and validation, sterilisation or packaging work and quality-system readiness. Where required, obtain the notified body's scope and schedule separately. Price preparation, tests, clinical work and assessment explicitly; missing device-specific evidence can determine the critical path.
Explain relevance to intended use and technical and biological characteristics. Assess equivalence conditions and data access; use for the same disease alone is insufficient. Develop a device-specific clinical evaluation and additional-data plan. Do not assume clinical investigation is universally required or universally unnecessary.
Assess effects of the new site, method or process on sterility and device characteristics. Review validation, packaging, shelf life and biological safety as needed. Follow the relevant notified body's change and notification rules. The same service name does not establish coverage by earlier evidence.
The exact records for MDR Cost and Timescale depend on the confirmed scope. Current, consistent and traceable information reduces avoidable revisions.
TRTürkçe
ENEnglish
AZAzərbaycanca
UZO‘zbekcha
ARالعربية
FRFrançais
DEDeutsch
RUРусский